Entresto 24 MG-26 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DR26F1F10
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $39,794
Award facts
- Contract value 100% obligated
- $39,794.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Entresto 24 mg-26 mg tablets (60-count units) with a contract ceiling value of approximately $39.8K. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded transaction. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of November 4, 2025. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1B prime pharmaceutical supply vehicle running through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Health Agency and related government healthcare entities. The company's extensive federal contract portfolio demonstrates its capability to fulfill comprehensive pharmaceutical and medical supply requirements across multiple therapeutic domains on a competitive basis. This Entresto order exemplifies the company's role in supplying cardiac medications and specialty pharmaceuticals to support military healthcare programs through DLA's pharmaceutical prime vendor system.
Quick answers
Who was awarded contract SPE2DR26F1F10?
SPE2DR26F1F10 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 3, 2025.
How much is contract SPE2DR26F1F10 worth?
The government has obligated $39,794 on SPE2DR26F1F10.
Is contract SPE2DR26F1F10 an order under another contract?
Yes. SPE2DR26F1F10 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1F10 competed?
The extent of competition for SPE2DR26F1F10 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award